Search results for "EXCIPIENTS"

showing 6 items of 56 documents

The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir

2019

Chitosan is object of pharmaceutical research as a candidate permeability enhancer. However, chitosan was recently shown to reduce the oral bioavailability of acyclovir in humans. The effect of chitosan on two processes determining the oral bioavailability of acyclovir, bioaccessibility and intestinal absorption, was now investigated. Acyclovir's bioaccessibility was studied using the dynamic TNO gastro-Intestinal Model (TIM-1). Four epithelial models were used for permeability experiments: a Caco-2 cell model in absence and presence of mucus and both rat and porcine excised intestinal segments. Study concentrations of acyclovir (0.8 g/l) and chitosan (1.6 g/l and 4 g/l) were in line with t…

SwineAcyclovirPharmaceutical ScienceBiocompatible Materials02 engineering and technologyPharmacology030226 pharmacology & pharmacyIN-VITRO EVALUATIONIntestinal absorptionChitosanchemistry.chemical_compound0302 clinical medicineDrug InteractionsPharmacology & PharmacyGeneral MedicinePermeation021001 nanoscience & nanotechnologyMOLECULAR-WEIGHTJejunum0210 nano-technologyLife Sciences & BiomedicineBiotechnologyAbsorption (skin)Antiviral AgentsPermeability03 medical and health sciencesOrgan Culture TechniquesIn vivomedicineAnimalsHumansBiologyABSORPTION ENHANCERSChitosanScience & TechnologyIntestinal permeabilityCACO-2Caco-2medicine.diseaseTRANSPORTRatsBioavailabilityMODELIntestinal AbsorptionchemistryCOMMON EXCIPIENTSCaco-2Intestinal tissue segmentsCaco-2 CellsTNO gastro-Intestinal Model (TIM-1)SYSTEMPOORLY ABSORBABLE DRUGSTRACTEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Transcutol containing vesicles for topical delivery of minoxidil

2010

The aim of this work was to evaluate the ability of Transcutol (Trc) to produce elastic vesicles with soy lecithin (SL) and study the influence of the obtained vesicles on in vitro (trans)dermal delivery of minoxidil. To this purpose, so-called penetration enhancer-containing vesicles (PEVs) were prepared using Trc aqueous solutions (5-10-20-30% v/v) as hydrophilic phase. SL liposomes, without Trc, were used as control. Prepared formulations were characterized in terms of size distribution, morphology, zeta potential, deformability, and rheological behavior. The influence of the obtained PEVs on (trans)dermal delivery of minoxidil was studied by in vitro diffusion experiments through pig sk…

SwineStereochemistryVasodilator AgentsPharmaceutical ScienceAdministration CutaneousDiffusionExcipientschemistry.chemical_compoundDrug Delivery SystemsDrug Stabilitystomatognathic systemPhosphatidylcholineLecithinsZeta potentialmedicineAnimalsParticle SizeMicroparticleSkinDrug CarriersLiposomeAqueous solutionChromatographyChemistryVesiclefungiPenetration (firestop)MinoxidilLiposomesMinoxidilEthylene Glycolsmedicine.drugJournal of Drug Targeting
researchProduct

Sorbitol-penetration enhancer containing vesicles loaded with baicalin for the protection and regeneration of skin injured by oxidative stress and UV…

2018

Abstract Aiming at improving the protective effects of baicalin on the skin, new highly-biocompatible penetration enhancer containing vesicles (PEVs) were developed by modifying the base formulation of transfersomes with sorbitol, thus obtaining sorbitol-PEVs. An extensive evaluation of the physico-chemical features of both transfersomes and sorbitol-PEVs was carried out. Transfersomes were mainly close-packed, multi-compartment vesicles, while sorbitol-PEVs appeared mostly as single, spherical, unilamellar vesicles. All the vesicles were small in size (∼128 nm) and negatively charged (∼−67 mV), without significant differences between the formulations. The in vitro delivery of baicalin to i…

SwineUltraviolet RaysChemistry PharmaceuticalCellPharmaceutical Science02 engineering and technologymedicine.disease_cause030226 pharmacology & pharmacyCell LineExcipients03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineDrug Delivery SystemsCell MovementmedicineAnimalsHumansRegenerationSorbitolParticle SizeCell ProliferationSkinFlavonoidsWound HealingCell growthVesicleRegeneration (biology)fungi3T3 Cells021001 nanoscience & nanotechnologyIn vitroOxidative Stressmedicine.anatomical_structurechemistryBiophysicsSorbitol0210 nano-technologyBaicalinOxidative stressInternational journal of pharmaceutics
researchProduct

Nortriptyline for smoking cessation: Release and human skin diffusion from patches

2009

Abstract The objective of this work was to develop a simple and inexpensive transdermal formulation containing Nortriptyline Hydrochloride (NTH) for smoking cessation support therapy. Hydroxypropyl-methyl-cellulose was chosen as polymer and a mixture of transdermal enhancers (selected from previous research) was incorporated. The formulations were characterised in terms of appearance, thickness, uniformity of NTH content, release and skin permeation. Release studies demonstrated controlled release for four formulations. Diffusion studies were performed through human heat separated epidermis (HHSE) using Franz Diffusion Cells (FDC). Patches provided different fluxes varying from 20.39 ± 7.09…

Time FactorsChemistry PharmaceuticalSkin AbsorptionPharmaceutical ScienceHuman skinNortriptylineIn Vitro TechniquesAdministration CutaneousPermeabilityDosage formExcipientsStratum corneummedicineHumansTransdermalMicroscopy ConfocalChromatographyAdrenergic Uptake Inhibitorsintegumentary systembusiness.industryPenetration (firestop)PermeationControlled releasemedicine.anatomical_structureNortriptyline HydrochlorideAnesthesiaMethacrylatesFemaleSmoking CessationbusinessInternational Journal of Pharmaceutics
researchProduct

The effect of excipients on the stability and phase transition rate of xylazine hydrochloride and zopiclone

2015

The compatibility of thermodynamically unstable polymorph of two active pharmaceutical compounds (xylazine hydrochloride form X and zopiclone form C) with different excipients was investigated. The effects of the excipient and its amount in the sample on the thermal properties and possible chemical interactions were studied. The most commonly used excipients in the pharmaceutical industry - calcium carbonate, lactose hydrate, cellulose, magnesium stearate hydrate and calcium stearate hydrate were selected for this study. The dependence of the phase transition rate from an unstable to a more stable polymorph on the excipients and their amounts in the initial sample was analysed at 80°C, and …

XylazinePhase transitionDrug IndustryClinical BiochemistryPharmaceutical ScienceExcipientCalcium stearatePhase TransitionPiperazinesAnalytical ChemistryExcipientschemistry.chemical_compoundReaction rate constantDrug StabilityDrug DiscoverymedicineMagnesium stearateCelluloseSpectroscopyChromatographyTemperatureKineticsCalcium carbonatechemistryThermodynamicsHydrateAzabicyclo CompoundsNuclear chemistrymedicine.drugJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems.

2017

First introduced in the second half of the 19th century, enteric coatings are commonly used to protect acid-labile drugs, reduce the risk of gastric side effects due to irritating drugs, or for local drug delivery to the lower gastrointestinal (GI) tract. The currently available enteric-coatings are based on pH-sensitive weakly acidic polymers. Despite the long history of their use, the causes behind their performance often being unpredictable have not been properly investigated with most of the attention being focused only on the gastric emptying. However, little attention has been given to the postgastric emptying disintegration and dissolution of these dosage forms. This lack of attentio…

medicine.medical_specialtyDrug LiberationIn vitro testChemistry PharmaceuticalPharmaceutical SciencePh dependentBiological Availability02 engineering and technologyPharmacologyIn Vitro Techniques030226 pharmacology & pharmacyDosage formBiopharmaceuticsExcipients03 medical and health sciences0302 clinical medicineDrug DiscoveryIntestine SmallmedicineIntensive care medicineGastric emptyingbusiness.industryHydrogen-Ion Concentration021001 nanoscience & nanotechnologyEnteric coatingBioavailabilityDrug LiberationSolubilityDrug deliveryMolecular MedicineTablets Enteric-Coated0210 nano-technologybusinessmedicine.drugMolecular pharmaceutics
researchProduct